Company page

Nurix Therapeutics, Inc.

Nurix Therapeutics, Inc. (ticker: NRIX) is a public company based in the United States, focused on developing innovative therapies for cancer and other diseases. With a market capitalization of approximately $2.4 billion, Nurix is engaged in advancing its proprietary drug discovery platform. The company aims to create targeted treatments that harness the body's natural processes to combat diseases effectively.